Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has issued an update.
Shanghai HeartCare Medical Technology Corporation Limited has announced the convening of its 2025 second extraordinary general meeting (EGM) to be held on August 29, 2025. The primary agenda is to consider and approve the utilization of the company’s capital reserve to offset significant losses amounting to RMB575,082,245.74. This move is in accordance with the company’s Articles of Association and relevant laws, indicating a strategic financial decision aimed at stabilizing the company’s financial standing.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a company based in the People’s Republic of China, specializing in medical technology. The company operates within the healthcare industry, focusing on developing and providing advanced medical solutions.
Average Trading Volume: 144,581
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.08B
Find detailed analytics on 6609 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money